The estimated Net Worth of John J Gorman is at least $65.1 millier dollars as of 5 September 2012. John Gorman owns over 4,600 units of Spero Therapeutics Inc stock worth over $65,124 and over the last 14 years John sold SPRO stock worth over $0.
John has made over 1 trades of the Spero Therapeutics Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently John bought 4,600 units of SPRO stock worth $8,740 on 5 September 2012.
The largest trade John's ever made was buying 4,600 units of Spero Therapeutics Inc stock on 5 September 2012 worth over $8,740. On average, John trades about 1,533 units every 0 days since 2011. As of 5 September 2012 John still owns at least 48,600 units of Spero Therapeutics Inc stock.
You can see the complete history of John Gorman stock trades at the bottom of the page.
John's mailing address filed with the SEC is 12 Skyline Dr, Hawthorne, NY 10532, USA.
Over the last 15 years, insiders at Spero Therapeutics Inc have traded over $15,920,732 worth of Spero Therapeutics Inc stock and bought 3,223,281 units worth $44,767,755 . The most active insiders traders include Plc Gsk, Jean Francois Formela et Capital Management, Llc Aqu.... On average, Spero Therapeutics Inc executives and independent directors trade stock every 71 days with the average trade being worth of $122,858. The most recent stock trade was executed by Ankit Mahadevia on 27 August 2024, trading 5,912 units of SPRO stock currently worth $7,981.
spero therapeutics is focused on the development of novel therapies to treat highly resistant bacterial infections. the culture at spero is one of respect, action, collaboration and transparency. spero team members are leaders in the field, and have the ability and desire to be a part of a team. at spero, a feeling that we are part of something groundbreaking and innovative fuels our approach.
Spero Therapeutics Inc executives and other stock owners filed with the SEC include: